497
Views
12
CrossRef citations to date
0
Altmetric
Case Report

Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature

, , &
Pages 628-631 | Received 04 Feb 2018, Accepted 27 Mar 2018, Published online: 04 Jun 2018

References

  • Perry CM, Markham A. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs. 1999;57(5):805–843. doi:10.2165/00003495-199957050-00017.
  • Gin A, Dilay L, Karlowsky JA, Walkty A, Rubinstein E, Zhanel GG. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. Expert Rev Anti Infect Ther. 2007;5(3):365–383. doi:10.1586/14787210.5.3.365.
  • Johansen ME, Jensen JU, Bestle MH, Hein L, Lauritsen AO, Tousi H, Larsen KM, Loken J, Mohr T, Thormar K, Johansson PI, Cozzi-Lepri A, Lundgren JD, Freson K. The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trial. PLoS One. 2013;8(11):e81477. doi:10.1371/journal.pone.0081477.
  • George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematol Am Soc Hematol Educ Program. 2009;153–158. doi:10.1182/asheducation-2009.1.153.
  • George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998;129(11):886–890. doi:10.7326/0003-4819-129-11_Part_1-199812010-00009.
  • Kumar A, Choudhuri G, Aggarwal R. Piperacillin induced bone marrow suppression: a case report. BMC Clin Pharmacol. 2003;3:2. doi:10.1186/1472-6904-3-2.
  • Lee KW, Chow KM, Chan NP, Lo AO, Szeto CC. Piperacillin/tazobactam induced myelosuppression. J Clin Med Res. 2009;1(1):53–55.
  • Perez-Vazquez A, Pastor JM, Riancho JA. Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis. 1998;27(3):650–651. doi:10.1086/517143.
  • Yan MT, Chu HY, Chau T, Lin SH. Profound thrombocytopenia associated with piperacillin in a hemodialysis patient. Clin Nephrol. 2009;72(3):240–243. doi:10.5414/CNP72240.
  • Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357(6):580–587. doi:10.1056/NEJMra066469.
  • Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7(6):911–918. doi:10.1111/j.1538-7836.2009.03360.x.
  • Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013;27(3):137–145. doi:10.1016/j.tmrv.2013.05.005.
  • Shaik S, Kazi HA, Ender PT. Rapid-onset piperacillin-tazobactam induced thrombocytopenia. J Pharm Pract. 2015;28(2):204–206. doi:10.1177/0897190014566302.
  • Rousan TA, Aldoss IT, Cowley BD Jr., Curtis BR, Bougie DW, Aster RH, George JN. Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol. 2010;85(1):71–74.
  • Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion. 2008;48(11):2429–2434. doi:10.1111/trf.2008.48.issue-11.
  • Park BK, Kitteringham NR, Powell H, Pirmohamed M. Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity. Toxicology. 2000;153(1–3):39–60. doi:10.1016/S0300-483X(00)00303-6.
  • Nguyen VD, Tourigny JF, Roy R, Brouillette D. Rapid-onset thrombocytopenia following piperacillin-tazobactam reexposure. Pharmacotherapy. 2015;35(12):e326–30. doi:10.1002/phar.1675.
  • Lin SY, Huang JC, Shen MC, Chuang SH, Lee MH, Chen HC. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient. Hemodial Int. 2012;16(Suppl 1):S50–3. doi:10.1111/j.1542-4758.2012.00745.x.
  • Chen H, Fan Z, Guo F, Yang Y, Li J, Zhang J, Wang Y, Le J, Wang Z, Zhu J. Tazobactam and piperacillin-induced thrombocytopenia: a case report. Exp Ther Med. 2016;11(4):1223–1226. doi:10.3892/etm.2016.3062.
  • Boyce K, Brar H, Stabler SN. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit. J Clin Pharm Ther. 2016;41(6):730–732. doi:10.1111/jcpt.2016.41.issue-6.
  • Bose S, Wurm E, Popovich MJ, Silver BJ. Drug-induced immune-mediated thrombocytopenia in the intensive care unit. J Clin Anesth. 2015;27(7):602–605. doi:10.1016/j.jclinane.2015.06.021.
  • Patel S, Levin-Epstein R, Kobashigawa J. Piperacillin-induced thrombocytopenia in a dual heart and kidney transplant patient: a case report. Transplant Proc. 2017;49(7):1672–1674. doi:10.1016/j.transproceed.2017.02.043.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.